febuxostat has been researched along with natriuretic peptide, brain in 3 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | febuxostat (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, A; Kinugawa, S; Murohara, T; Okumura, T; Tsutsui, H; Yokota, T | 1 |
| Kamatani, N; Kushiyama, A; Toyo-Oka, L; Toyo-Oka, T | 1 |
| Akasaki, Y; Eguchi, K; Fukumoto, Y; Kamiya, H; Kario, K; Kusunose, K; Node, K; Sata, M; Tanaka, A; Teragawa, H; Yamada, H; Yoshida, H | 1 |
2 trial(s) available for febuxostat and natriuretic peptide, brain
| Article | Year |
|---|---|
Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Febuxostat; Female; Gout Suppressants; Heart Failure; Hospitalization; Humans; Hyperuricemia; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Fragments; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2018 |
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study.
Topics: Awards and Prizes; Diastole; Febuxostat; Humans; Hyperuricemia; Natriuretic Peptide, Brain; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
1 other study(ies) available for febuxostat and natriuretic peptide, brain
| Article | Year |
|---|---|
Treatment of two mitochondrial disease patients with a combination of febuxostat and inosine that enhances cellular ATP.
Topics: Adenosine Triphosphate; Aged, 80 and over; Cardiomyopathies; Diabetes Mellitus; Febuxostat; Female; Humans; Hypoxanthine; Inosine; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Natriuretic Peptide, Brain; Reactive Oxygen Species | 2019 |